VP, Pharma Business Development

Oxford Brain Diagnostics (OBD) is redefining how neurodegenerative disease is measured. Our proprietary Cortical Disarray Measurement (CDM®) technology uses standard MRI to quantify subtle changes in brain microstructure, creating objective measures with the potential to improve the characterization and longitudinal assessment of neurodegenerative disease.

As disease-modifying therapies become an increasingly important part of clinical practice, physicians, health systems, researchers, and pharmaceutical companies need scalable, objective measures that can help characterize disease, monitor progression, and evaluate therapeutic response.

OBD is seeking a senior, quota-carrying business development leader to build and close strategic partnerships with pharmaceutical and biotechnology companies developing therapies for neurological disease.

This is a hands‑on individual‑contributor role for an experienced enterprise seller who can both create pipeline and close complex opportunities. You will own the commercial cycle from account targeting and prospecting through solution development, negotiation and close, with a particular focus on expanding early CDM engagements into larger, multi‑year clinical development programmes.

You will work closely with OBD's Commercial, Marketing, Science and Technology teams to develop solutions spanning exploratory biomarker work, patient stratification and longitudinal monitoring in clinical trials.

The ideal candidate combines a strong understanding of drug development with the commercial discipline to navigate complex, multi-stakeholder sales cycles and build enduring relationships with pharmaceutical and biotechnology customers.

Build and Own the Pharma Pipeline

• Own an annual bookings target and build a qualified pipeline sufficient to deliver against it.
• Identify and prioritize pharmaceutical and biotechnology accounts based on neurology and CNS focus, development stage and potential fit with CDM.
• Generate new opportunities through direct outreach, existing relationships, conferences, partnerships and coordinated marketing programmes.
• Develop strategic account plans for priority customers and identify opportunities to expand individual projects into broader relationships.

Lead Complex Enterprise Deals

• Lead the full commercial process from initial engagement and needs assessment through solution design, proposal, pricing, contracting and close.
• Navigate multiple stakeholders across clinical development, translational medicine, imaging, biomarker, procurement and legal functions.
• Develop consultative, value‑based proposals that connect CDM to specific drug‑development challenges and decisions.
• Work with the CCO and CEO on strategic pricing, major contracts and larger partnership opportunities.

Grow Clinical Trial and CDM Track Business

• Build compelling value propositions around patient characterization, stratification, longitudinal monitoring and clinical trial endpoints.
• Expand successful exploratory and pilot engagements into larger, recurring and multi‑year programmes.
• Develop CDM Track as a strategic component of OBD's pharmaceutical and clinical trial business.
• Partner closely with Science and Technology to ensure solutions are scientifically credible, operationally feasible and aligned with customer needs.

Build Strategic Customer Relationships

• Develop trusted relationships with senior leaders in clinical development, neuroscience, translational medicine, biomarkers and related functions.
• Understand customers' development portfolios and identify opportunities where CDM can address meaningful scientific or…